BRCA2-IN-2 (Compound 3i) exhibits strong binding affinity with the BRCA2 protein. This compound effectively inhibits the proliferation of breast cancer cells and can eliminate DPPH radicals. BRCA2-IN-2 also demonstrates both antitumor and antioxidant activities.
Target:
Reactive Oxygen Species|||ROS
* VAT and and shipping costs not included. Errors and price changes excepted
